Moderna's flu vaccine shows promise in early-stage study
- World
- Reuters
- Published Date: 03:28 | 10 December 2021
- Modified Date: 03:28 | 10 December 2021
Moderna Inc said on Friday its experimental seasonal flu vaccine produced robust antibodies in an early stage study in younger and older adults.
The early-stage study is ongoing, and a mid-stage study testing the messenger RNA-based vaccine is now fully enrolled, the company said.
OTHER WORLD NEWS
- Trump slams Afghan withdrawal 'incompetence' on 9/11 anniversary
- Bus bomb kills two in Afghan capital: Taliban
- Erdoğan vows Turkey will continue to stand by oppressed all over the world
- U.S. House Capitol Jan. 6 probe subpoenas more Trump aides
- Western states urge Tunisia return to democratic institutions